Five biological processes and pathways were screened, namely the MAPK signaling pathways, non-small cell lung cancer, regulation of actin cytoskeleton, PI3K-Akt signaling pathway, and EGFR tyrosine kinase inhibitor resistance. This evidence concerns the gene EGFR and non-small cell lung carcinoma.